Collegium Pharmaceutical Stock Forecast - Period Momentum Indicator
| COLL Stock | USD 30.41 0.41 1.37% |
Collegium Stock Forecast is based on your current time horizon. Although Collegium Pharmaceutical's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Collegium Pharmaceutical's systematic risk associated with finding meaningful patterns of Collegium Pharmaceutical fundamentals over time.
Collegium |
| Check Collegium Pharmaceutical Volatility | Backtest Collegium Pharmaceutical | Information Ratio |
Collegium Pharmaceutical Trading Date Momentum
| On November 21 2024 Collegium Pharmaceutical was traded for 30.41 at the closing time. The top price for the day was 30.95 and the lowest listed price was 29.96 . The trading volume for the day was 457.4 K. The trading history from November 21, 2024 did not affect price variability. The overall trading delta against the current closing price is 1.38% . |
Generally speaking extended values of the momentum indicator over time are good indicators of oversold or over brought conditions.
| Compare Collegium Pharmaceutical to competition |
Other Forecasting Options for Collegium Pharmaceutical
For every potential investor in Collegium, whether a beginner or expert, Collegium Pharmaceutical's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Collegium Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Collegium. Basic forecasting techniques help filter out the noise by identifying Collegium Pharmaceutical's price trends.Collegium Pharmaceutical Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Collegium Pharmaceutical stock to make a market-neutral strategy. Peer analysis of Collegium Pharmaceutical could also be used in its relative valuation, which is a method of valuing Collegium Pharmaceutical by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Collegium Pharmaceutical Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Collegium Pharmaceutical's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Collegium Pharmaceutical's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Collegium Pharmaceutical Market Strength Events
Market strength indicators help investors to evaluate how Collegium Pharmaceutical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Collegium Pharmaceutical shares will generate the highest return on investment. By undertsting and applying Collegium Pharmaceutical stock market strength indicators, traders can identify Collegium Pharmaceutical entry and exit signals to maximize returns.
Collegium Pharmaceutical Risk Indicators
The analysis of Collegium Pharmaceutical's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Collegium Pharmaceutical's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting collegium stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.88 | |||
| Standard Deviation | 2.37 | |||
| Variance | 5.64 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of Collegium Pharmaceutical to cross-verify your projections. For more information on how to buy Collegium Stock please use our How to buy in Collegium Stock guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Collegium Pharmaceutical. If investors know Collegium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Collegium Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.49) | Earnings Share 2.34 | Revenue Per Share 18.538 | Quarterly Revenue Growth 0.165 | Return On Assets 0.0968 |
The market value of Collegium Pharmaceutical is measured differently than its book value, which is the value of Collegium that is recorded on the company's balance sheet. Investors also form their own opinion of Collegium Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Collegium Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Collegium Pharmaceutical's market value can be influenced by many factors that don't directly affect Collegium Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Collegium Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Collegium Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Collegium Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.